- Home
- REKR vs DERM Comparison
REKR vs DERM Comparison
Compare REKR & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- DERM
- Stock Information
- Founded
- REKR 2017
- DERM 2014
- Country
- REKR United States
- DERM United States
- Employees
- REKR N/A
- DERM N/A
- Industry
- REKR Telecommunications Equipment
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- REKR Telecommunications
- DERM Health Care
- Exchange
- REKR Nasdaq
- DERM Nasdaq
- Market Cap
- REKR 151.6M
- DERM 165.6M
- IPO Year
- REKR N/A
- DERM 2021
- Fundamental
- Price
- REKR $1.10
- DERM $6.95
- Analyst Decision
- REKR
- DERM Strong Buy
- Analyst Count
- REKR 0
- DERM 3
- Target Price
- REKR N/A
- DERM $12.67
- AVG Volume (30 Days)
- REKR 1.8M
- DERM 213.9K
- Earning Date
- REKR 08-12-2025
- DERM 08-12-2025
- Dividend Yield
- REKR N/A
- DERM N/A
- EPS Growth
- REKR N/A
- DERM N/A
- EPS
- REKR N/A
- DERM N/A
- Revenue
- REKR $45,380,000.00
- DERM $56,397,000.00
- Revenue This Year
- REKR $8.89
- DERM $28.10
- Revenue Next Year
- REKR $20.55
- DERM $53.84
- P/E Ratio
- REKR N/A
- DERM N/A
- Revenue Growth
- REKR 7.05
- DERM N/A
- 52 Week Low
- REKR $0.62
- DERM $3.54
- 52 Week High
- REKR $2.67
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- REKR 44.67
- DERM 42.68
- Support Level
- REKR $1.07
- DERM $7.23
- Resistance Level
- REKR $1.22
- DERM $7.51
- Average True Range (ATR)
- REKR 0.06
- DERM 0.32
- MACD
- REKR 0.00
- DERM -0.04
- Stochastic Oscillator
- REKR 42.86
- DERM 28.09
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.